Publications by authors named "Michael Lauw"

Claim this Profile
H
HTX-019 via 2-min injection or 30-min infusion in healthy subjects.
Thomas Ottoboni, Michael Lauw, Mary Rose Keller, Matt Cravets, Kimberly Manhard

Future Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects.
Tom Ottoboni, Michael Lauw, Mary Rose Keller, Matt Cravets, Kimberly Manhard

Future Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis